WEDNESDAY, Aug. 31, 2022 (HealthDay News) — When teenagers with type 1 diabetes get better control of their blood sugar, their brains may benefit, a new clinical trial shows. Researchers found that when teenagers started treatment with a newer technology — often dubbed “artificial pancreas” systems — they were betterContinue Reading

WEDNESDAY, Aug. 24, 2022 (HealthDay News) — People with type 2 diabetes might face a substantially increased risk of heart failure if they take ibuprofen or some other type of nonsteroidal anti-inflammatory drug (NSAID), a new Danish study indicates. Short-term NSAID use increased risk of hospitalization for heart failure byContinue Reading

FRIDAY, Aug. 5, 2022 (HealthDay News) – Kids with type 1 diabetes and their closest relatives are more likely to experience mental health issues than people without the disease, Swedish researchers report. “Many clinicians assume intuitively that diabetes in a child negatively affects the mental health of both the patientContinue Reading

WEDNESDAY, July 27, 2022 (HealthDay News) — A half-century-old diabetes drug appears to help treat bipolar disorder by reversing patients’ insulin resistance, according to a small-scale clinical trial. Bipolar patients who responded to the drug metformin experienced improvement in their mood disorder as their insulin resistance decreased, said lead researcherContinue Reading

SUNDAY, July 24, 2022 (HealthDay News) — Living in a region where tropical storms, hurricanes or other weather emergencies are likely means being ready for a quick evacuation. “Part of preparedness is having a plan,” said Dr. James McDeavitt, executive vice president and dean of clinical affairs at Baylor CollegeContinue Reading